glp 1 receptor agonist drug names glp-1 GLP-1 Receptor Agonists: An Alternative for Rapid-Acting Insulin? PDB-101: Molecule of the Month:

Since these medications cause functional rather than structural changes, gastric function generally returns to baseline

doi: 10.1152/japplphysiol.00223.2015

o Biocon Limited Advanced Pipeline Companies o Boehringer Ingelheim International GmbH o Amgen Inc

The ozempic segment dominated the market with a 32.15% market share in 2025 due to its strong clinical performance

Schematic representation of the main pathophysiological mechanisms (lipotoxicity, oxidative stress, inflammation, and gut-liver axis) and therapies under evaluation directed at these processes, including THR- agonists, FGF-21 analogs, pan-PPAR modulators, GLP-1 RAs, and GLP-1/GIP combinations, in addition to conventional treatments such as SGLT-2 inhibitors, metformin, statins, and vitamin E